Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability of L-Praziquantel ODT vs Racemate Praziquantel in Healthy Volunteers
NCT02271984Phase 1Completed
- Sponsor
- Merck KGaA
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levopraziquantel in schistosomiasis (5 arms), sponsored by Merck KGaA. Primary endpoint: Area Under the Plasma Concentration-time Curve From Time Zero to Infinity. Started Oct 2014; status: completed.
02
Drugs
levopraziquantel
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on NCT02271984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271984.